|« Previous month||Next month »|
31-Oct-2012 - Regulators in Non-EU countries can use results of previous inspections of API plants by EU or equivalent authorities in written confirmations, according to the European Commission.
31-Oct-2012 - Lonza will cut jobs at its facility in Visp, Switzerland and may enact similar 'productivity improvement programmes’ at other sites.
31-Oct-2012 - German drugmaker Boehringer Ingelheim (BI) plans to double production capacity at its inhaler plant in citing demand.
31-Oct-2012 - The positive impact drug industry demand for quality is having on the fine chemicals sector was evident at industry trade show CPhI last month according to expert Jan Ramakers.
31-Oct-2012 - New Zealand regulator Medsafe and the Taiwan FDA will join the Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme (PIC/S) next year.
30-Oct-2012 - Pharmaceutical firms should let the EMA know about minor variations to marketing authorisation (MA) by the end of next month if they want to avoid delays over the festive period.
30-Oct-2012 - All parties involved in the distribution of biologics in India must take responsibility for quality and keep seasonal temperature variations in mind says the CDSCO.
30-Oct-2012 - Menarini has committed millions of euros to an antibody drug conjugate (ADC) clinical development and manufacturing pact with Oxford BioTerapeutics (OBT).
29-Oct-2012 - Novartis says two seasonal influenza vaccines temporarily banned by several European countries on quality concerns are safe.
29-Oct-2012 - A group combining government agencies and biotechnology firms have established what it claims is the first cell therapy development facility in France.
29-Oct-2012 - A new delivery device should reduce the risk posed by the availability of high-dose insulin in Europe say regulators, but vigilance is still needed.
25-Oct-2012 - Big Pharma firms want a Republican in the White House judging by contributions received by the two US parties during the current campaign.
25-Oct-2012 - Rx360 wants industry feedback on import requirements for active pharmaceutical ingredients (API) due to be introduced next year.
24-Oct-2012 - The UK Intellectual Property Office (IPO) wants to make it easier to develop drugs in the country by changing the rules relating to patent infringement in clinical trials.
24-Oct-2012 - Evonik has raised the price of its pharmaceutical amino acids as a result of rising maize and sugar costs.
24-Oct-2012 - Regulator Health Canada has started a consultation on plans to extend GMP requirements to active pharmaceutical ingredients (API).
23-Oct-2012 - The EMA wants feedback on its plans to revise testing requirements for bovine serum used to manufacture biologics.
23-Oct-2012 - Pharmas should use lower API and excipient volumes if seeking authorisation under the EU Paediatric Investigation Plan (PIP) says the EMA.
23-Oct-2012 - Rubicon Research and Avantor have teamed up to develop a gastro-retentive excipient for pharmaceutical applications.
23-Oct-2012 - in-PharmaTechnologist.com presents its weekly round-up of career changes in the pharmaceutical industry, including news from Heptares, Cerecor and Dyax Corp.
23-Oct-2012 - A medicated chewing gum prototype that combats motion sickness could give a platform to incorporate other active ingredients with objectionable tastes into gum.
22-Oct-2012 - Watson and acquisition target Actavis must sell 18 drugs to rivals Sandoz and Par Pharma under conditions imposed by the US Federal Trade Commission (FTC).
22-Oct-2012 - Indian drugmaker Dr Reddy’s wants to buy Netherland’s-based formulation services firm Octoplus to expand its drug delivery technology portfolio.
|« Previous month||Next month »|